Annual Working Capital
$13.44 M
-$17.86 M-57.06%
December 31, 2023
Summary
- As of February 10, 2025, ONTX annual working capital is $13.44 million, with the most recent change of -$17.86 million (-57.06%) on December 31, 2023.
- During the last 3 years, ONTX annual working capital has risen by +$3.68 million (+37.66%).
Performance
ONTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$8.73 M
-$4.71 M-35.04%
March 31, 2024
Summary
- As of February 10, 2025, ONTX quarterly working capital is $8.73 million, with the most recent change of -$4.71 million (-35.04%) on March 31, 2024.
- Over the past year, ONTX quarterly working capital has dropped by -$4.71 million (-35.04%).
Performance
ONTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ONTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.1% | -35.0% |
| 3 y3 years | +37.7% | -35.0% |
| 5 y5 years | +44.1% | -35.0% |
ONTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.7% | at low | -82.3% | at low |
| 5 y | 5-year | -72.7% | -27.4% | -83.5% | at low |
| alltime | all time | -85.7% | -161.5% | -91.8% | -158.1% |
Onconova Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $8.73 M(-35.0%) |
| Dec 2023 | $13.44 M(-57.1%) | $13.44 M(-22.5%) |
| Sep 2023 | - | $17.34 M(-20.4%) |
| Jun 2023 | - | $21.78 M(-15.6%) |
| Mar 2023 | - | $25.82 M(-17.5%) |
| Dec 2022 | $31.30 M(-36.5%) | $31.30 M(-14.0%) |
| Sep 2022 | - | $36.41 M(-12.4%) |
| Jun 2022 | - | $41.57 M(-8.5%) |
| Mar 2022 | - | $45.43 M(-7.9%) |
| Dec 2021 | $49.31 M(+405.1%) | $49.31 M(-6.8%) |
| Sep 2021 | - | $52.91 M(+44.2%) |
| Jun 2021 | - | $36.69 M(-11.2%) |
| Mar 2021 | - | $41.32 M(+323.3%) |
| Dec 2020 | $9.76 M(-35.7%) | $9.76 M(-37.9%) |
| Sep 2020 | - | $15.71 M(-18.3%) |
| Jun 2020 | - | $19.24 M(-22.9%) |
| Mar 2020 | - | $24.97 M(+64.4%) |
| Dec 2019 | $15.18 M(+62.8%) | $15.18 M(-733.4%) |
| Sep 2019 | - | -$2.40 M(+656.2%) |
| Jun 2019 | - | -$317.00 K(-111.4%) |
| Mar 2019 | - | $2.78 M(-70.2%) |
| Dec 2018 | $9.33 M | $9.33 M(-37.4%) |
| Sep 2018 | - | $14.90 M(-26.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $20.18 M(-1110.6%) |
| Mar 2018 | - | -$2.00 M(-60.6%) |
| Dec 2017 | -$5.07 M(-139.3%) | -$5.07 M(+1698.9%) |
| Sep 2017 | - | -$282.00 K(-104.6%) |
| Jun 2017 | - | $6.12 M(-6.3%) |
| Mar 2017 | - | $6.53 M(-49.4%) |
| Dec 2016 | $12.91 M(-17.1%) | $12.91 M(-31.7%) |
| Sep 2016 | - | $18.89 M(+174.0%) |
| Jun 2016 | - | $6.89 M(-41.4%) |
| Mar 2016 | - | $11.76 M(-24.5%) |
| Dec 2015 | $15.58 M(-57.5%) | $15.58 M(-8.5%) |
| Sep 2015 | - | $17.03 M(-2.6%) |
| Jun 2015 | - | $17.49 M(-31.7%) |
| Mar 2015 | - | $25.59 M(-30.2%) |
| Dec 2014 | $36.65 M(-61.0%) | $36.65 M(-24.6%) |
| Sep 2014 | - | $48.58 M(-21.5%) |
| Jun 2014 | - | $61.88 M(-20.1%) |
| Mar 2014 | - | $77.47 M(-17.6%) |
| Dec 2013 | $94.05 M(+62.5%) | $94.05 M(-12.2%) |
| Sep 2013 | - | $107.09 M(+144.8%) |
| Jun 2013 | - | $43.74 M(+4.8%) |
| Mar 2013 | - | $41.74 M(-27.9%) |
| Dec 2012 | $57.87 M(-800.4%) | $57.87 M |
| Dec 2011 | -$8.26 M | - |
FAQ
- What is Onconova Therapeutics annual working capital?
- What is the all time high annual working capital for Onconova Therapeutics?
- What is Onconova Therapeutics annual working capital year-on-year change?
- What is Onconova Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly working capital year-on-year change?
What is Onconova Therapeutics annual working capital?
The current annual working capital of ONTX is $13.44 M
What is the all time high annual working capital for Onconova Therapeutics?
Onconova Therapeutics all-time high annual working capital is $94.05 M
What is Onconova Therapeutics annual working capital year-on-year change?
Over the past year, ONTX annual working capital has changed by -$17.86 M (-57.06%)
What is Onconova Therapeutics quarterly working capital?
The current quarterly working capital of ONTX is $8.73 M
What is the all time high quarterly working capital for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly working capital is $107.09 M
What is Onconova Therapeutics quarterly working capital year-on-year change?
Over the past year, ONTX quarterly working capital has changed by -$4.71 M (-35.04%)